Fundraising Fox
/Companies
Sign in

River BioMedics

13 employees on LinkedIn · 6 known investors

Find your way into River BioMedics

Sign up to see every warm intro you have to River BioMedics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the River BioMedics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies. It focuses on treatments for cardiac diseases by targeting biological processes involved in their pathology.

BiotechHealthtechMedical Devices

Founders & leadership

RPRobert Passier
Robert PassierFounderRobert Passier is a professor of applied stem cell technologies at the University of Twente and the University of Leiden Medical Centre with 25 years of research experience in cardiac differentiation and disease using transgenic models and human pluripotent stem cells. He holds multiple patents in cardiac stem cell technologies and is co-founder of River BioMedics, which develops human cardiac tissue models for drug discovery and validation.

Investors · 6

KIKK Capitallisted by KIKK CapitalRoosendaal · $540K – $1.6M

How we know: KIKK Capital's portfolio page · funding news · biogenerationventures.com · open dataset · 5k.vc investor directory · Not right? Tell us

BGVreportedSilicon Valley

How we know: funding news · Not right? Tell us

Oost NLreportedApeldoorn · $108K – $5.4M

How we know: funding news · biogenerationventures.com · Not right? Tell us

Also in the syndicate · 2

BioGeneration Ventures (BGV)FIRST fundlead

Funding

SEC filings, press & company announcements
  • Undisclosed amountseed funding roundJan 2022 · 2 sources

    FIRST fund (lead), KIKK Capital (lead), Oost NL (lead), BioGeneration Ventures (BGV)

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does River BioMedics do?
River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies. It focuses on treatments for cardiac diseases by targeting biological processes involved in their pathology.
Who founded River BioMedics?
River BioMedics was founded by Robert Passier.
Who are River BioMedics's investors?
River BioMedics's investors include BioGeneration Ventures, KIKK Capital, BGV, Oost NL.